Cargando…
Antiviral neutralizing antibodies: from in vitro to in vivo activity
Neutralizing antibodies (nAbs) are being increasingly used as passive antiviral reagents in prophylactic and therapeutic modalities and to guide viral vaccine design. In vivo, nAbs can mediate antiviral functions through several mechanisms, including neutralization, which is defined by in vitro assa...
Autor principal: | Burton, Dennis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108814/ https://www.ncbi.nlm.nih.gov/pubmed/37069260 http://dx.doi.org/10.1038/s41577-023-00858-w |
Ejemplares similares
-
The antiviral activity of antibodies in vitro and in vivo
por: Parren, Paul W.H.I., et al.
Publicado: (2001) -
Neutralizing antiviral antibody responses
por: Zinkernagel, Rolf M., et al.
Publicado: (2001) -
Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017) -
Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013) -
Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)